Kari Furu

11.7k total citations · 2 hit papers
157 papers, 5.0k citations indexed

About

Kari Furu is a scholar working on Public Health, Environmental and Occupational Health, Pediatrics, Perinatology and Child Health and Psychiatry and Mental health. According to data from OpenAlex, Kari Furu has authored 157 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Public Health, Environmental and Occupational Health, 39 papers in Pediatrics, Perinatology and Child Health and 29 papers in Psychiatry and Mental health. Recurrent topics in Kari Furu's work include Maternal Mental Health During Pregnancy and Postpartum (36 papers), Pregnancy and Medication Impact (29 papers) and Attention Deficit Hyperactivity Disorder (16 papers). Kari Furu is often cited by papers focused on Maternal Mental Health During Pregnancy and Postpartum (36 papers), Pregnancy and Medication Impact (29 papers) and Attention Deficit Hyperactivity Disorder (16 papers). Kari Furu collaborates with scholars based in Norway, Sweden and Denmark. Kari Furu's co-authors include Svetlana Skurtveit, Anders Engeland, Helga Zoëga, Aage Tverdal, Jaana E. Martikainen, Øystein Karlstad, Randi Selmer, Morten Andersen, Helle Kieler and Björn Wettermark and has published in prestigious journals such as New England Journal of Medicine, JAMA and Nucleic Acids Research.

In The Last Decade

Kari Furu

155 papers receiving 4.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Association of Prenatal Exposure to Antiseizure Medication With Risk of Autism and Intellectual Disability

2022 118 citations Marte‐Helene Bjørk, Helga Zoëga et al. profile →
Safety of GLP-1 Receptor Agonists and Other Second-Line Antidiabetics in Early Pregnancy

2023 68 citations Carolyn E. Cesta, Jacqueline M. Cohen et al. profile →

Peers

Countries citing papers authored by Kari Furu

Since Specialization

Citations

This map shows the geographic impact of Kari Furu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kari Furu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kari Furu more than expected).

Fields of papers citing papers by Kari Furu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kari Furu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kari Furu. The network helps show where Kari Furu may publish in the future.

Co-authorship network of co-authors of Kari Furu

This figure shows the co-authorship network connecting the top 25 collaborators of Kari Furu. A scholar is included among the top collaborators of Kari Furu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kari Furu. Kari Furu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Pharmacological treatment of obesity in adults in Norway 2004–2022 2024 ·Diabetes Obesity and Metabolism ·Paz Lopez‐Doriga Ruiz, Øystein Karlstad, (unknown), (unknown), Hanne Løvdal Gulseth, Helmut E. Meyer, Kari Anne Sveen, Elisabeth Qvigstad, Kari Furu	6
2	Antipsychotic use during pregnancy and risk of specific neurodevelopmental disorders and learning difficulties in children: a multinational cohort study 2024 ·EClinicalMedicine ·(unknown), Carolyn E. Cesta, Vidar Hjellvik, Sinna Pilgaard Ulrichsen, Marte‐Helene Bjørk, Buket Öztürk Esen, M. Gillies, Mika Gissler, Alys Havard, Øystein Karlstad, Maarit K. Leinonen, Mette Nørgaard, Sallie‐Anne Pearson, Johan Reutfors, Kari Furu, Jacqueline M. Cohen, Helga Zoëga	5
3	Trajectories of ADHD medication use before, during, and after pregnancy: A population‐based study from Norway and Sweden 2023 ·Pharmacoepidemiology and Drug Safety ·(unknown), Øystein Karlstad, Hein Stigum, Kari Furu, Carolyn E. Cesta, Johan Reutfors, Jacqueline M. Cohen	5
4	Metformin Versus Insulin and Risk of Major Congenital Malformations in Pregnancies With Type 2 Diabetes: A Nordic Register-Based Cohort Study 2023 ·Diabetes Care ·Lars J. Kjerpeseth, Carolyn E. Cesta, Kari Furu, Anders Engeland, Mika Gissler, Hanne Løvdal Gulseth, Øystein Karlstad, Maarit K. Leinonen, Laura Pazzagli, Helga Zoëga, Jacqueline M. Cohen	11
5	Prevalence trends and individual patterns of ADHD medication use in pregnancy in Norway and Sweden, 2010–2019 2022 ·European Journal of Clinical Pharmacology ·Jacqueline M. Cohen, (unknown), Kari Furu, Carolyn E. Cesta, Johan Reutfors, Øystein Karlstad	12
6	Use of non‐insulin antidiabetic drugs in children and young adults – A Scandinavian drug utilization study from 2010–2019 2021 ·British Journal of Clinical Pharmacology ·Helene Kildegaard, Lotte Rasmussen, Kari Furu, Øystein Karlstad, Marie Linder, Carolyn E. Cesta, Anton Pottegård	2
7	Prevalence trends and individual patterns of antiepileptic drug use in pregnancy 2006‐2016: A study in the five Nordic countries, United States, and Australia 2020 ·Pharmacoepidemiology and Drug Safety ·Jacqueline M. Cohen, Carolyn E. Cesta, Kari Furu, Kristjana Einarsdóttir, Mika Gissler, Alys Havard, Sonia Hernández–Dı́az, Krista F. Huybrechts, Helle Kieler, Maarit K. Leinonen, Jiong Li, Johan Reutfors, Andrea L. Schaffer, Randi Selmer, Yongfu Yu, Helga Zoëga, Øystein Karlstad	36
8	Ssri/snri discontinuation in pregnancy and obstetrical outcomes: A nordic population register-based study 2020 ·STM:n Hallinnonalan avoin julkaisuarkisto (Julkari) ·Carolyn E. Cesta, Óskar Hálfdánarson, Jacqueline M. Cohen, Kristjana Einarsdóttir, Kari Furu, Mika Gissler, Maarit K. Leinonen, Mette Nørgaard, Johan Reutfors, (unknown), Helga Zoëga, (unknown), Helle Kieler	1
9	Risk factors for stroke and choice of oral anticoagulant in atrial fibrillation 2018 ·European Journal of Clinical Pharmacology ·Lars J. Kjerpeseth, Hanne Ellekjær, Randi Selmer, Inger Ariansen, Kari Furu, Eva Skovlund	5
10	Cancer Risk in Women Treated with Fertility Drugs According to Parity Status—A Registry-based Cohort Study 2017 ·Cancer Epidemiology Biomarkers & Prevention ·(unknown), Ritsa Storeng, Tor Åge Myklebust, Nan Birgitte Oldereid, Anne Katerine Omland, Trude Eid Robsahm, Louise A. Brinton, Siri Vangen, Kari Furu, Inger Kristin Larsen	46
11	Trends in use of warfarin and direct oral anticoagulants in atrial fibrillation in Norway, 2010 to 2015 2017 ·European Journal of Clinical Pharmacology ·Lars J. Kjerpeseth, Hanne Ellekjær, Randi Selmer, Inger Ariansen, Kari Furu, Eva Skovlund	71
12	Use of drugs for ADHD among adults—a multinational study among 15.8 million adults in the Nordic countries 2016 ·European Journal of Clinical Pharmacology ·Øystein Karlstad, Helga Zoëga, Kari Furu, Shahram Bahmanyar, Jaana E. Martikainen, Helle Kieler, Anton Pottegård	37
13	Selective Serotonin Reuptake Inhibitors and Venlafaxine in Early Pregnancy and Risk of Birth Defects 2015 ·Obstetrical & Gynecological Survey ·Kari Furu, Helle Kieler, Bengt Haglund, Anders Engeland, Randi Selmer, Olof Stephansson, Unnur Valdimarsdóttir, Helga Zoëga, Miia Artama, Mika Gissler, Heli Malm, Mette Nørgaard	1
14	Teratogenicity of Selective Serotonin-Reuptake Inhibitors and Venlafaxine - A Population-Based Study of 2.3 Million Births in Five Nordic Countries 2014 ·STM:n Hallinnonalan avoin julkaisuarkisto (Julkari) ·Kari Furu, Helle Kieler, Bengt Haglund, Helga Zoëga, Mika Gissler, Mette Nørgaard	1
15	Risk of Fetal Death After Pandemic Influenza Virus Infection or Vaccination 2013 ·Obstetrical & Gynecological Survey ·Siri E. Håberg, Lill Trogstad, Nina Gunnes, Allen J. Wilcox, Håkon K. Gjessing, Sven Ove Samuelsen, Anders Skrondal, Inger Cappelen, Anders Engeland, Preben Aavitsland, Steinar Madsen, Ingebjørg Buajordet, Kari Furu, Per Nafstad, Dan J. Stein, Berit Feiring, Hanne Nøkleby, Per Magnus, Camilla Stoltenberg	9
16	Selective Serotonin Reuptake Inhibitors During Pregnancy and Risk of Stillbirth and Infant Mortality 2013 ·Survey of Anesthesiology ·Olof Stephansson, Helle Kieler, Bengt Haglund, Miia Artama, Anders Engeland, Kari Furu, Mika Gissler, Mette Nørgaard, Marie Germund Nielsen, Helga Zoëga, Unnur Valdimarsdóttir	6
17	Selective serotonin reuptake inhibitors during pregnancy and risk of persistent pulmonary hypertension in the newborn: population based cohort study from the five Nordic countries 2011 ·Geogaceta ·Helle Kieler, Miia Artama, Anders Engeland, Örjan Ericsson, Kari Furu, Mika Gissler, Marie Germund Nielsen, Mette Nørgaard, Olof Stephansson, Unnur Valdimarsdóttir, Helga Zoëga, B Haglund	193
18	The use of lithium, valproate or lamotrigine for psychiatric conditions in children and adolescents in Norway 2004–2007 — A prescription database study 2009 ·Journal of Affective Disorders ·Jørgen G. Bramness, Berit Grøholt, Anders Engeland, Kari Furu	10
19	Prescription drug use among fathers and mothers before and during pregnancy. A population‐based cohort study of 106 000 pregnancies in Norway 2004–2006 2008 ·British Journal of Clinical Pharmacology ·Anders Engeland, Jørgen G. Bramness, Anne Kjersti Daltveit, Marit Rønning, Svetlana Skurtveit, Kari Furu	153
20	Determinants of control of high blood pressure. The Oslo Health Study 2000–2001 2004 ·Blood Pressure ·Serena Tonstad, Kari Furu, Elin Olaug Rosvold, Svetlana Skurtveit	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact